WCRX Related Mergers and Acquisitions
-
Valeant (VRX) Continues Deal Hunt; Close to Buying Bausch & Lomb for $9B
-
Warner Chilcott (WCRX) / Actavis (ACT) Deal Features $160M Termination Fee
-
UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through
-
Actavis (ACT) to Acquire Warner Chilcott (WCRX) in $8.5B Deal
-
Warner Chilcott plc (WCRX) Halted News Pending
-
UPDATE: Correct: Buying Warner Chilcott plc (WCRX) Seen as Takeover Defense by Actavis (ACT)
-
Warner Chilcott (WCRX) Could Fetch Premium in Deal with Actavis (ACT)
-
Actavis (ACT) Affirms Merger Talks with Warner Chilcott (WCRX)
-
Warner Chilcott (WCRX) Halted News Pending
-
Warner Chilcot (WCRX) Ends Talks to Sell Company; to Declare $4.00 Special Dividend, Will Start Semi-Annual Dividend at 50c/Share
-
Needham & Company Maintains a 'Hold' on Warner Chilcott (WCRX); Valuation Paradox
-
Warner Chilcott (WCRX) Confirms Review of Strategic Alternatives
-
Canaccord Genuity Maintains a 'Buy' on Warner Chilcott (WCRX); Taking A Closer Look
-
Warner Chilcott (WCRX) Shares Jump Amid Bayer $32/Share Takeover Rumor
-
Warner Chilcott (WCRX) Terminates Co-Promotion Pact with Novartis (NVS); to Make $400M Payment for US Rights to Enablex
-
Warner Chilcott (WCRX) Sells Rights to Psoriasis Treatments to LEO Pharma for $1B
-
Warner Chilcott (WCRX) Confirms Purchase of P&G's Global Pharma Business for $3.1B
Back to WCRX Stock Lookup
